1 completed, 1 recruiting. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Recruiting 1 |
Follow Abrexa Pharmaceuticals, Inc.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Efficacy of J147 in Acute Ischemic Stroke J147 Emulsion for Injection, Placebo - Acute Ischemic Stroke | Phase 2 | Recruiting | Abrexa Pharmaceuticals, Inc. | 196 | 2026-07-22 | 2026-08-24 |
| Study to Assess the Safety, Tolerability and Pharmacokinetics of Single Ascending Oral Doses of J147 J147, Placebo - Alzheimer's Disease | Phase 1 | Completed | Abrexa Pharmaceuticals, Inc. | 64 | 2019-01-22 | 2020-09-03 |
Alzheimer Disease (1) · Dementia (1) · Ischemic Stroke (1) · Neurodegenerative Diseases (1) · Stroke (1)
Injections (1) · J147 (1)
United States (2)
Marguerite Prior, Ph.D. (1) · Martin Kankam, MD, PhD, MPH (1) · Steven J Warach, MD, PhD (1)